News
-
-
-
PRESS RELEASE
Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning -
-
-
PRESS RELEASE
Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business
Gerresheimer sees revenue growth in H1 2025, driven by Bormioli Pharma acquisition. Subdued demand in cosmetics and oral liquids market. Positive long-term outlook despite challenges -
PRESS RELEASE
Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
Formycon completes patient enrollment for clinical development of Keytruda biosimilar FYB206. Results expected in Q1 2026. Streamlined program accelerates development -
PRESS RELEASE
SenseRobot Debuts at AI for Good Global Summit 2025, Showcasing China's AI Innovations to the World
SenseRobot President Mark Ma presented at the United Nations AI for Good Global Summit 2025, showcasing China's AI innovation. The session highlighted AI's role in enhancing human learning, family bonds, and inclusion -
-
PRESS RELEASE
PJX Resources Announces Non-Brokered Private Placement Of $1.6 Million
PJX Resources Inc. announces non-brokered private placement of units for gross proceeds of $1,652,460. Private Placement expected to close on July 15, 2025. Company to use proceeds for exploration and working capital in British Columbia
